Morton Brown Family Wealth »

Regeneron Pharmaceuticals shares owned by Morton Brown Family Wealth

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Morton Brown Family Wealth from 13F filings

Historical chart of Morton Brown Family Wealth investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Morton Brown Family Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Morton Brown Family Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $624 1 624.00
2023-03-31 $2.5k 3 821.67

More positions owned by Morton Brown Family Wealth

Schwab U.s. Broad Market Etf Etf (SCHB)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Avantis U.s. Small Cap Value Etf Etf (AVUV)
Avantis International Small Cap Value Etf Etf (AVDV)
Ishares National Muni Bond Etf Etf (MUB)
Schwab Intermediate-term Us Treasury Etf Etf (SCHR)
State Street Spdr S&p 500 Etf Etf (SPY)
Vanguard Intermediate-term Corporate Bond Etf Etf (VCIT)
Ishares Global Reit Etf Etf (REET)
Vanguard Total International Bond Etf Etf (BNDX)
Pimco Intermed Muni Bond Etf (MUNI)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Ishares Short-term National Muni Bond Etf Etf (SUB)
Ishares Msci Eafe Etf Etf (EFA)

View all positions for Morton Brown Family Wealth

Top funds holding Regeneron Pharmaceuticals

BlackRock
Vanguard Capital Management
Dodge & Cox
State Street Corporation
Invesco
Jpmorgan Chase & Co
Vanguard Portfolio Management
Franklin Resources
Geode Capital Management
T. Rowe Price Associates
Nuveen
Loomis, Sayles and
Capital World Investors
Goldman Sachs Group
Morgan Stanley

View all funds holding Regeneron Pharmaceuticals